Cases
Cases
Redeemer Health is pursuing a sale of its hospital and physician network while preparing for a possible hospital wind-down and restructuring its other care businesses. The court has authorized interim use of bondholders’ cash collateral and set a final hearing for December 14, 2026; the interim order Dkt. 86 also requires a bid-procedures motion within 14 days of the November 1 petition date.
Redeemer Health and its affiliates are in Chapter 11 pursuing a sale of Holy Redeemer Hospital and the physician network, with a hospital wind-down contemplated if a going-concern sale cannot be achieved. The debtors also intend to preserve and reorganize their post-acute and life-care businesses. The board concluded that continued hospital operations were unsustainable, according to the first-day declaration Dkt. 7.
The nonprofit health system filed on November 1, 2026, after years of hospital and physician-network losses, liquidity pressure, delayed vendor payments and defaults on bond debt. The declaration reports annual acute-care losses ranging from $31.6 million to $48.9 million over five years. The bond trustee asserted approximately $77 million in outstanding bond debt, secured in part by the hospital property and receipts, as described in the cash collateral motion Dkt. 21.
The court authorized Holy Redeemer Health System and HR Physician & Ambulatory Services to use the bond trustee’s cash collateral on an interim basis under a budget, with replacement and supplemental liens as adequate protection. The interim cash collateral order Dkt. 86 requires investment-banker retention and bid-procedures motions within 14 days of the petition date, subject to extension or waiver by the trustee. The debtors reported that four health systems had signed nondisclosure agreements and were conducting due diligence in the cash collateral motion Dkt. 21.
A final cash collateral hearing is scheduled for December 14, 2026, and the bond collateral authorization runs no later than that date unless extended or otherwise changed under the order. The court also authorized interim use of pharmaceutical creditors’ cash collateral through the final hearing in a separate order Dkt. 103.
Updated Nov 13
Case facts and filing dates come from court records.Case docket on PACER